1Hurwitz HI, Fehrenbacher L, Hainsworth JD, et al.Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer [J].J Clin Oncol, 2005,23 (15): 3502-3508. 被引量：1
2Kabbinavar F, Hurwitz H, Fehrenbacher L, et al. Phase Ⅱ,randomized trial comparing bevacizumab plus fluorouracil(FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer [J]. J Clin Oncol, 2003,21:60-65. 被引量：1
3Yang JC, Haworth L, Sherry RM, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer [J]. N Engl J Med, 2003,349(5):427-434. 被引量：1
4Saif MW, Mehra R. Incidence and management of bevacizumabrelated toxicities in colorectal cancer [J]. Expert Opin Drug Saf, 2006,5(4):553-566. 被引量：1
5Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase Ⅱ trial comparing bevacizumab plus ca.rboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer [J]. J Clin Oncol, 2004,22(11):2184-2191. 被引量：1
6Hillan KL, Koeppen HKW, Tobin P, et al. The role of VEGF expression in response to bevaeizumab plus eapecitabine in metastatic breast cancer(MBC) [J]. Proc Am Soc Clin Oncol,2003,22:191. 被引量：1
7Kabbinavar FF, Schulz J, McCleod M, et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase Ⅱ trial [J]. J Clin Oncol, 2005,23(16): 3697-3705. 被引量：1
8Giantonio BJ, Catalano PJ, Meropol NJ, et al. High-dose bevacizumab in combination with FOLFOX4 improves survival in patients with previously treated advanced colorectal cancer:Results from the Eastern Cooperative Oncology Group (ECOG) study E3200 [J]. 2005 ASCO Gastrointestinal Cancers Symposium, Abstract 169a. 被引量：1
8Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solide tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [ J ]. J Natl Cancer Inst,2000 ,92 :205 被引量：1
9Goldberg RM, Sargent DJ, Morton RF et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinationgs inpatients with previously untreated metastatic colorectal cancer[ J]. J Clin Oncol, 2004,22 : 23 被引量：1
10de Gramont A, Figer A, Seymour M et al. Leucovorin and fluorouracil with or without oxaliplatin as first - line treatment in advanced colorectal cancer [ J ]. J Clin Oncol,2000,18:2938 被引量：1
